🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Neurofeedback for Nociplastic Pain in Rheumatoid Arthritis (NECTAR)

RecruitingNAAges 18 Years - 75 YearsAllNHS Greater Glasgow and Clyde
NCT06240299 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Rheumatoid arthritis is an autoimmune condition, causing inflammation and pain. Yet pain may persist even when inflammation has been treated. This residual pain, called nociplastic pain, has symptoms of a chronic pain condition called fibromyalgia. There are few effective therapies to address this residual pain. Published literature shows that fibromyalgia can be treated by neurofeedback, a noninvasive method that is based on the voluntary modulation of cortical activity. In this pilot study, the investigators want to test the effect of neurofeedback on the fibromyalgia component of pain in rheumatoid arthritis, and also to investigate its effects on related symptoms such as fatigue and sleep disturbance.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Fulfilment of the ACR/EULAR Classification Criteria for rheumatoid arthritis (RA) * Fulfilment of the American College of Rheumatology criteria for chronic widespread pain * Stable disease (swollen joint count ≤1 and CRP ≤10) * Has normal or corrected to normal vision and hearing abilities * Right-handed (to reduce baseline motor response test heterogeneity) * Pain intensity equal or larger than 4 on the Visual Numerical Scale (0 no pain, 10, max pain imaginable) Exclusion Criteria: * Unable to understand the task. * Unable to provide a written informed consent. * Unable to understand English. * Major confounding neurological diseases including Multiple Sclerosis, Stroke, Traumatic Brain Injury, Parkinson's Disease, and Alzheimer's Disease) * Medical or psychiatric conditions that in the judgment of study personnel would preclude participation in the study (psychosis, suicidal ideation etc) * Under active management of pain team (changing medications, other non pharmacological pain treatment) * Involved in other interventional experimental studies
💊

What it tests

  • Neurofeedback
📍

Where

1 site
Clinical Research Facility (CRF), Queen Elizabeth University Hospital
Glasgow, United Kingdom
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy